Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + Ifosfamide in Soft Tissue Sarcoma
NCT00541840Phase 2Unknown
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in soft tissue sarcoma (STS), sponsored by Spanish Group for Research on Sarcoma. Primary endpoints: Safety profile, Maximum Tolerated Dose and 1 more. Status: unknown.
02
Drugs
sorafenib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00541840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541840.